Novel Colon Cancer Therapeutic Target Identified
The protein Importin-11 transports the cancer-causing protein βcatenin into the nucleus of colon cancer cells, where it can drive cell proliferation.
Related Articles
JPM: More “Smaller, Smarter” M&A Deals Expected in 2025, EY Predicts
EY—the professional services firm originally known as Ernst & Young—reports the dollar value of biopharma M&A deals nosedived 51% during 2024, to 92 from 186…
To Reverse Aging’s Clock, Adjust the Cell’s Machinery
Epigenetic, bioelectromic, synaptic, and senolytic interventions could rejuvenate cells and counter the effects of aging.
J&J to Acquire Intra-Cellular for $14.6B
Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.
Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing
Timberlyne Therapeutics launched last week with a $180 million Series A financing to advance CM313.
Mutation Mechanism Found That Drives the Aggressive Development and Evolution of Osteosarcoma
The new insights on osteosarcome could, with time, lead to better treatment options and outcomes for patients through more targeted care.
JPM: More “Smaller, Smarter” M&A Deals Expected in 2025, EY Predicts
EY—the professional services firm originally known as Ernst & Young—reports the dollar value of biopharma M&A deals nosedived 51% during 2024, to 92 from 186…
J&J to Acquire Intra-Cellular for $14.6B
Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.
Unlocking the Potential of Ketones and Esters Could Streamline Drug Development
Scripps Research chemists unlock the potential of ketone and ester molecules, paving the way for greener and more efficient drug development.
Samsung Extends Collaboration with LigaChem for ADC Development
Samsung’s ADC segregated suite, equipped with a 500-liter reactor, supports the development and manufacture of ADC therapies.
Potential New Obesity Target Found in Mitochondrial Protein Involved in Brown Fat Thermogenesis
Experiments showed that when mitochondrial protein MCJ is removed from obese mice the animals produce more heat and lose weight.